BioCentury
ARTICLE | Company News

NICE now backs Oncotype with discount

February 20, 2013 1:14 AM UTC

The U.K.'s NICE now recommends the use of Oncotype DX from Genomic Health Inc. (NASDAQ:GHDX) after the company said it would provide the breast cancer diagnostic at an undisclosed discount under a pat...